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ABSTRACT Transformation of murine thymocytes by
radiation leukemia virus is associated with reduced expression
of the class I antigens encoded in the major histocompatibility
complex (MHC) and increased methylation and altered restric-
tion enzyme patterns of MHC DNA. These changes may play
a role in host susceptibility to virus-induced leukemogenesis
and accord with the notion that viral genomes play a regulatory
function when they integrate adjacent to histocompatibiity
genes.
Associations between malignant disease and the murine
major histocompatibility complex, MHC, have been exten-
sively demonstrated (1), and various mechanisms have been
proposed. In studies of MHC-linked resistance to neoplasia
induced by radiation leukemia virus (RadLV) (2-5), we found
dramatic alterations in the quantitative expression of some
cell surface class I MHC antigens associated with infection
and transformation of thymocytes. Several prior findings
have suggested that these changes in H-2 antigen expression
result from direct effects of RadLV on H-2 transcription (5,
6). In addition, as shown below, levels of class I mRNA are
considerably reduced in cells transformed by RadLV, and
transformation by RadLV is associated with methylation and
rearrangements of MHC DNA.
MATERIALS AND METHODS
Mice. Mice used were bred at the New York University
Medical Center, purchased from The Jackson Laboratory, or
obtained from Chella David's colony at the Mayo Clinic.
Cell Cultures. In vitro adapted tumors of various inbred
mouse strains were maintained in Dulbecco's modified Ea-
gle's mediurh (DMEM) supplemented with 10% fetal bovine
serum, 1% penicillin/streptomycin solution, and 0.1%
Fungizone.
Hybridization Probes. Probes used in this study have been
previously described by others: pH-21I (7), Thy-i (8), py2b
(9), pp62-microglobulin (10), and ,B-actin probe (11).
DNA Procedures. DNAs were isolated by the procedure of
Blin and Stafford (12) and concentrations were determined
spectrophotometrically by the diphenylamine method. Fif-
teen micrograms of DNA was digested with 60 units of
enzyme in the buffer recommended by New England Biolabs,
containing bovine serum albumin at 100 ,Lg/ml. Incubations
were carried out in 50 Al at 37°C for 16 hr to ensure
completeness of digestion. This was monitored by withdraw-
ing 10 A.l of the 50-,ul reaction mixture 2 min after starting and
placing it in a tube containing 2 t.l of X phage DNA (0.75
ng/ttl) or adenovirus DNA (0.75 ng//l), 32P-labeled by
nick-translation to low specific activity (-107 cpm/,ug). At
the end of digestion the reactions were stopped by addition
of 12.5 pLI ofbromophenol blue loading buffer containing 20%
Ficoll, 1 mM disodium ethylenediaminetetraacetate (EDTA),
and 0.2% bromophenol blue. Results were confirmed in
several independent experiments. DNAs were electropho-
resed in 0.8% agarose gels (Bethesda Research Laboratories)
overnight and transferred to nitrocellulose (Schleicher &
Schuell BA85) by the method of Southern (13). The 12-/il
samples (see above) were loaded into another agarose gel,
electrophoresed, dried, and autoradiographed to monitor
completeness of digestion.
mRNA Isolation. mRNA was isolated out by the procedure
of Feramisco et al. (14) with a slight modification. About 1.0
x 108 cells were homogenized in 10 ml of 4 M guanidine
isothiocyanate/140 mM 2-mercaptoethanol/2.0% Sarkosyl/
50 mM Tris-HCl, pH 7.6/10 mM EDTA. Samples were
extracted with phenol several times at 60'C, once with an
equal volume of phenol/chloroform containing 4% (vol/vol)
isoamyl alcohol, and finally with chloroform and 4% isoamyl
alcohol; all were carried out in 0.1 M sodium acetate (pH 5.9).
The nucleic acids were precipitated with 2.5 times the sample
volume of ethanol (EtOH) overnight at -20TC. Nucleic acids
were pelleted at 15,000 x g for 30 min, dried in a desiccator,
and resuspended with 3 ml of 10 mM Tris HCl, pH 7.5/2 mM
EDTA/0.2% NaDodSO4. Samples were incubated 5 min at
650C to unfold secondary RNA structure. After 8 min of
incubation on ice, NaCl was added to a 400 mM final
concentration. The samples were placed over an oligo(dT)-
cellulose (Calbiochem) column to bind mRNA (15, 16).
mRNA was eluted from the column with 10 mM Tris.HCl/2
mM EDTA/0.2% NaDodSO4 heated to 450C. NaCl was
added to the mRNA sample to 400 mM final concentration
and then the mRNA was precipitated as above with EtOH
and stored at -70°C until needed for electrophoresis.
mRNA Electrophoresis. Samples (10 jig) were resuspended
with 4.5 ,ul of water/10 ,l of99% (vol/vol) formamide/3.5 ,ul
of37% (vol/vol) formnaldehyde/2 ,l of 10x buffer [10x bpffer
= 200 mM 3(N-morpholino)propanesulfonic acid (Mops)/50
mM sodium acetate/10 mM EDTA], heated at 65°C for 10
min, and placed on ice for 5 min. Five microliters of
bromophenol blue loading buffer was added, and the mRNAs
were loaded into a 1% agarose gel containing formaldehyde
Abbreviations: MHC, major histocompatibility complex; RadLV,
radiation leukemia virus; kb, kilobase(s); RFLP, restriction fragment
length polymorphism.
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and electrophoresed overnight at 15 mA. Gels were blotted
onto nitrocellulose, rinsed in 6x SSC (lx SSC = 0.15 M
NaCl/0.015 M sodium citrate), and baked 5 hr at 80'C under
reduced pressure.
Hybridization Procedures (for Both DNA and RNA). Only
stringent conditions were used. After baking the filters were
placed in 100 ml per filter of blocking solution consisting of
6x SSC and Denhardt's solution (0.02% Ficoll, 0.02% bovine
serum albumin, and 0.02% polyvinylpyrrolidone), pre-
warmed to 650C. After incubation for 5 hr in a waterbath at
650C with shaking, the filters were removed, air dried, placed
in a heat-sealable plastic bag with hybridization solution
consisting of 2x SSC, 0.01 M EDTA, 32P-labeled denatured
probe (labeled to at least 1.0 x 108 cpm/,ug), and denatured
calf thymus DNA at 5 ug/ml, and incubated overnight at
650C. Nick-translations were performed with New England
Nuclear Kit NEK 004B. The filters were then washed three
times for 20 min in 2x SSC/0.5% NaDodSO4/20 mM
monobasic sodium phosphate/2.7 mM disodium pyrophos-
phate at 650C, once in lx SSC, then 0.4x SSC, and finally
with 0.1x SSC until the Cerenkov radioactivity was below
100 cpm/5 ml. Filters containing mRNA were blocked with
0.1% Ficoll at 650C for 1 hr and then incubated at 420C in 50%
(vol/vol) formamide/5x Denhardt's solution/50 mM sodium
phosphate, pH 6.8/5 mM EDTA/0.1% NaDodSO4/750 mM
NaCl/5 mg of denatured calf thymus DNA per ml for 4 hr.
Denatured probe, labeled to _108 cpm/,ug, was then added
and incubated with the filter for =16 hr at 42°C. Filters were
washed as above except that the first three 2x SSC washes
were carried out at room temperature instead of 65°C.
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RESULTS
RadLV Transformation Is Associated with a Decreased
Expression of H-2 Class I mRNAs. Fig. 1 shows that class I
mRNA is undetectable in RadLV tumors. This is consistent
with our previous observations that transformation of thy-
mocytes by RadLV leads to a loss of H-2 antigen expression
as measured by two-dimensional gel electrophoresis, immu-
nofluorescence, absorption analysis, and immunopre-
cipitation (2). This loss is particularly impressive in that the
probe used in these experiments, pH-2II, is broadly cross-
reactive, hybridizing with all K, D, L, Qa, and TL class I
genes.
Changes in Methylation of MHC DNA Are Associated with
RadLV-Induced Transformation of Murine Thymocytes. Fig.
2A and B compares autoradiograms ofDNAs from untreated
mouse thymocytes and RadLV-induced, in vitro adapted
tumors of various inbred strains after digestions with restric-
tion enzymes Msp I and Hpa II followed by Southern gel
electrophoresis and hybridization with a MHC DNA probe
(7). Msp I and Hpa II both recognize the same sequence
(CCGG), but digestion with Hpa II is inhibited when the
second cytosine residue is methylated. The Msp I digests of
RadLV tumor and normal thymic DNAs are identical, but the
Hpa II patterns of DNA from RadLV-induced tumors are
consistently different (in 100% of the more than 30 tumors
examined) from those of normal thymus. For example, in the
3- to 10-kb region there are more restriction fragments visible
in the lane that contains DNA from C57BL/6 RadLV-
transformed cells than in the lane that contains DNA from
normal cells (fragments 11-16 for RadLV and 7 and 8 for
normal) (Fig. 2A). Several fragments (nos. 1-4) between 5
and 10 kb present in normal B10.G DNA are absent or altered
in DNA from the RadLV-transformed counterparts (Fig. 2A).
Since the only additional fragments seen in DNA from
RadLV-transformed B1O.G cells are 5 and 6, the missing
fragments have probably not been cleaved from higher
molecular weight fragments because hypermethylation inhib-
FIG. 1. Comparison of class I MHC mRNA levels in normal
mouse thymocytes and splenocytes with those of RadLV-induced
thymomas. (A) Expression of H-2, shown with the pH-211 probe, is
observed in both normal cell types ofeach of the three mouse strains,
while there is a considerable reduction of H-2 in the corresponding
thymoma. (B) Expression of 83-actin mRNA is unaffected by RadLV
transformation.
its digestion by Hpa II. In T7/T7 RadLV-transformed cells
(Fig. 2B) numerous fragments present in the Hpa II pattern
of normal cells (nos. 17-22) are not detectable, presumably
for similar reasons. In B10.S transformed cells (Fig. 2B)
fragments 24-31, present in the normal cells, are not detect-
able; new fragments (nos. 32-35) appear, having higher
molecular weights than the normal fragments.
To confirm that the observed changes in Hpa II digestion
patterns of H-2 DNA seen in RadLV-transformed cells are
related to transformation and not merely a result of adapta-
tion to growth in vitro, several leukemic mice in which
thymomas had been induced by RadLV were sacrificed, and
their DNAs were prepared immediately. DNA from
thymomas of these mice also revealed differences with their
normal counterparts after Hpa II digestions (Fig. 2 C and D).
For example, fragments 1-3 present in normal B10 cells are
absent from tumor 50068 (Fig. 2C). In general the mean
molecular weight of new fragments in the tumor cells (nos.
4-9) is higher than that of missing fragments in normal cells.
In tumors 53101 and 56412 the pattern of Hpa II fragments
differs significantly from that in the normal Hpa II digest (Fig.
2D). Again, the new Hpa II fragments in tumor DNA (nos.
12-16) are at higher molecular weights than those unique to
normal DNA (nos. 10 and 11).
One result obtained in these studies is that every tumor
appears to have unique alterations in methylation, even
RadLV tumors derived from the same mouse strain (see Fig.
2 C and D). Since every tumor consistently gives the same
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4506 Immunology: Meruelo et al.
A B
B10. G C57BL /6J
No rtn . l Ra d LV No r mal Rad LV
M M lH M H rM
IJ M H M H M H kb
T 7/ T 7
r ~
BIO. S
_
Normal Rad LV Normal Rad LV
M H M H M H M H
Ia W ... %
4 7 _~
N1.. :.. _ _ _ _
-~~~~~~ a
w.^so 9~~~~~~~~~~~~~~~~~~~~
23.67
__ -- 9.46
2 6 * 45
.66
3
5 ~4.20
--_- 2.30
1.97
dI.-av -o
n7 fio 4
25
023 4__
21 3
*~~~~~~~
:22 _ --
W_ _n
_ _ 1~~~~3
C D
BlO
Tumor
No.
Normal 50066
M H M H
BlO. AQR
Tumor
no.
50068
I I
U H
Tumor
HO.
Normal 53101
1U H IUI H
Tumor
no.
56412
IM I
E
C57BL /6J B1O.Q
Thymus Spleen Thymus Spleen
*I N H U H UII
'W.-
'
+
-I
2; _
fto low
_
",11
-* - _ _
-23.67_~~
_42 _1lt w _ w _ w g ~-9.46
~ ~ ~ am
Z.
_ _ _| _| + -4.20
low
- 2.30
- 1.97
_ _ _
-
qw V
-
m
FIG. 2. (A and B) Comparison of H-2 DNA fragments from normal thymocytes and RadLV-induced thymomas, adapted to in vitro growth
(as discussed in ref. 4), after digestion with restriction endonucleases Msp I (M) or Hpa 11 (H). (C and D) Comparison of H-2 DNA fragments
from normal thymocytes and RadLV-induced thymomas removed immediately after sacrifice of moribund leukemic mice after digestion with
restriction endonuclease Msp I and Hpa II. (E) Comparison ofH-2 DNA fragments from normal thymocytes and splenocytes oftwo inbred mouse
strains after digestion with restriction endonucleases Msp I and Hpa II. Small numbers within the gel refer to individual restriction fragments.
Numbers outside gels indicate molecular sizes of markers in kilobases (kb).
methylation pattern whenever it is assayed (in uncloned cell
lines), this implies that alterations in methylation occur
before the tumorigenic cells expand from a limited number of
transformed cells. This notion would be consistent with a
clonal origin for most RadLV tumors.
We sought to determine whether RadLV-associated
changes in H-2 DNA methylation are related to normal
regulatory influences that affect H-2 expression in various
organs. On average, thymocytes express about one-fifth to
one-tenth as much H-2 antigens as splenocytes do (17), yet no
differences between splenocytes and thymocytes are detect-
ed in the Msp I or Hpa II pattern of digestion (Fig. 2E). Thus
methylation of H-2 DNA is associated with RadLV transfor-
mation but not with normal regulatory influences affecting
H-2 expression in these cells.
An important question is whether the altered patterns of
methylation associated with RadLV transformation are also
found elsewhere (non-MHC) in the genome. We examined
genes other than those coded by the MHC, such as Thy-i,
y2b, and 832-microglobulin (f32M). DNA from at least 20
kb
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tumors derived in vivo and in vitro were analyzed with probes
specific for these genes (8-10). No differences were observed
between the Msp I or Hpa II digestion of Thy-i DNA from
RadLV-transformed and uninfected/transformed thymo-
cytes (data not shown). Similar results were obtained for
f32-microglobulin. In the case of y2b no changes were ob-
served except that DNA from one of several tumors exam-
ined appeared to be less methylated than normal DNA (data
not shown).
Rearrangements of Class I DNA Regions Are Associated with
RadLV Tumorigenesis. Rearrangements in MHC DNA also
appear to accompany RadLV transformation as detected by
digestion with restriction enzymes. Two examples ofprimary
tumors in which restriction fragment length polymorphisms
(RFLPs) are detected with class I probes are shown in Fig.
3 A and B. Novel fragments are not detected with probes for
other genes such as y2b and 832M (Fig. 3A). In the case of
tumor 47589 (Fig. 3B) metastasis to the spleen had occurred
and both thymus and spleen display the RFLPs (Fig. 3 B and
C0). While tumors with RFLPs are seen less frequently than
tumors with changed DNA methylation patterns by using
restriction enzymes (we have RFLPs in at least four addi-
tional in vitro adapted cell lines and one tumor from which
DNA was made immediately after removal from the animal
out of 25 tumors examined), it is difficult to ascertain the true
incidence of tumors with novel RFLPs because of the
multiplicity of fragments hybridizing with H-2 probes. A
displacement of a fragment to a different location in a gel may
be masked by a fragment of the same size already present in
normal DNA.
It was of interest to determine more precisely which class
I genes were methylated and rearranged. While these studies
are still preliminary and will be the subject of future publi-
cations, it is possible to conclude that alterations in methyla-
tion associated with RadLV appear to affect numerous class
I genes, while RFLPs involve a more limited number of class
I genes. We also find less extensive alterations in MHC DNA
methylation, but no rearrangements, in some tumors induced
by radiation and viruses other than RadLV (data not shown).
DISCUSSION
While the mechanisms of resistance to leukemogenesis are
not known in many instances, host resistance to RadLV-
induced neoplasia has been shown to rely on immune
mechanisms responding to different quantitative levels ofH-2
antigen expression (4). Since such expression might be
markedly affected by both alterations in methylation and
rearrangements of class I genes, these changes might play an
important role in resistance to disease. Similar mechanisms
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FIG. 3. Comparison of genomic DNA from
normal thymocytes and RadLV-induced thymo-
mas removed immediately after sacrifice of
moribund leukemic mice. Thymoma DNA (tu-
mor 50068) was digested with restriction endo-
nuclease EcoRI. (A) Hybridization was done
with 32P-labeled pBR322, pH-211 (7), py2b (11),
and a probe for 82M recognizing a segment of
genomic DNA that encodes amino acids 3-95 of
32-microglobulin and approximately 300 base
pairs of intervening sequences (18). Novel
RFLPs were observed only with the H-2 probe
kb and were confirmed in additional experiments.(Other novel RFLPs are shown in the next two
S23.6 panels.) N, normal thymocytes; R, RadLV-
-9.4 induced thymoma. (B and C). Comparison of
r6.6 H-2 DNA fragments of normal thymocytes and
4.2 splenocytes with those of thymocytes and sple-
nocytes of RadLV-leukemic mouse 47589, in
< which thymoma cells had metastasized to the
spleen. Digestion was with EcoRI. (D) Absence
2.3 of class I-related, novel RFLPs in tumors in-
1.9 duced by AKR virus (BW5147) or Moloney
leukemia virus (YAC-1). DNA from these and
other tumors (not shown) of non-RadLV origin
were digested with a variety of restriction en-
zymes and hybridized with H-2 probes. BamHI
digest is shown as an example.
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may apply to other tumors. Taken together with our recent
findings of integrated viral sequences adjacent to numerous
histocompatibility genes (19, 20), the data in this paper are
consistent with the possibility that type C RNA viruses may
interact with histocompatibility genes to alter their expres-
sion in a physiologically important manner.
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